In most of the reported works, the authors established in vivo orthotopic tumor mice models and verified that modification of NPs’ surface with Tf molecules enhanced the GBM targeting ability, leading to better therapeutic outcomes (Figure 5). This evidence concerns the gene TF and glioblastoma.